菌体-抗生素组合在各种治疗方式中用于管理MRSA感染
Archana Loganathan1, Bulent Bozdogan2, Prasanth Manohar1
1School of Bioscience and Technology, Vellore Institute of Technology (VIT), Vellore, India.
Frontiers in pharmacology
|April 25, 2024
概括
菌体-抗生素联合治疗显示出对抗甲素耐药黄金葡萄球菌 (MRSA) 感染的增强疗效. 当在菌体后给予抗生素时,可以获得最佳的结果,改善治疗结果.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素耐药性对治疗细菌感染构成重大威胁,特别是在重症监护室 (ICU).
- 菌体-抗生素联合治疗正在成为对抗多药耐药性感染的关键策略.
研究的目的:
- 为了研究葡萄状菌体vB_Sau_S90和四种抗生素对抗抗甲素耐药黄金葡萄球菌 (MRSA) 的联合作用.
- 评估菌体-抗生素组合的不同剂量序列,以确定最佳的治疗策略.
主要方法:
- 实验使用三个治疗序列进行:菌体第一,同时和抗生素第一.
- 检查板分析用于评估协同效应,并计算了分数抑制度 (FIC) 指数.
- 在体内有效性使用Galleria mellonella模型进行了测试,以评估生物膜感染的幼虫.
主要成果:
- 与单独的菌体相比,菌体-抗生素组合显著增加了斑块大小.
- 在菌体和抗生素之间观察到协同效应,FIC值低于0.5.
- 组合疗法证明了普遍的疗效,当抗生素随着菌体的使用后得到最佳结果时.
- 在体内研究显示,在用生物膜感染的菌氧素治疗的Galleria mellonella幼虫中,生存率高达80%.
结论:
- 菌体-抗生素联合治疗对MRSA感染的单一治疗具有优势.
- 给药时间至关重要,因为菌体后的抗生素输送显示出更高的有效性.
- 这种结合方法对治疗具有挑战性的MRSA感染,包括那些具有生物膜的感染,具有前景.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:30Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
01:28Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
00:57Antibiotic Selection
53.3K
Overview
53.3K
01:23Antimicrobial Proteins
984
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
984